文献速递多重用药老年慢病共病管理

健康生活方式与全因死亡率的关联:按用药负担分层分析

Association of healthy lifestyle and all-cause mortality according to medication burden.
PubMed 文献 · J Am Geriatr Soc · 2021-10-25

该研究基于REGARDS队列20,417名≥45岁成人的二次分析,按用药数量分层(无多重用药0-4种、多重用药5-9种、超多重用药≥10种),采用Cox回归分析健康生活方式行为与全因死亡率的关联。结果显示,除超多重用药组的久坐避免外,各健康生活方式行为的最健康类别均与较低全因死亡率相关,且健康行为综合评分在各用药负担层均与死亡率呈负相关。结论认为,无论用药负担和年龄如何,更坚持健康生活方式均与较低全因死亡率相关。

要点

  • 地中海饮食、体力活动、戒烟在各用药负担层均与较低全因死亡率相关。
  • 健康行为综合评分越高,各用药负担层全因死亡率越低。
  • 超多重用药组中避免久坐与死亡率关联未达显著。

核心结论

  • 更坚持健康生活方式与较低全因死亡率相关,且不受用药负担和年龄影响。

研究设计与样本

  • REGARDS队列研究的二次分析,纳入20,417名年龄≥45岁成人。
  • 按用药数量分为无多重用药(0-4种)、多重用药(5-9种)和超多重用药(≥10种)三层。
  • 采用Cox比例风险回归模型分析各用药负担层内健康生活方式行为与死亡率的关联,并检验与年龄的交互作用。

主要发现

  • 地中海饮食最健康类别与较低全因死亡率相关:无多重用药HR 0.77,多重用药HR 0.78,超多重用药HR 0.85。
  • 体力活动最健康类别与较低全因死亡率相关:无多重用药HR 0.87,多重用药HR 0.82,超多重用药HR 0.79。
  • 戒烟与较低全因死亡率相关:无多重用药HR 0.40,多重用药HR 0.45,超多重用药HR 0.52。
  • 避免久坐与较低全因死亡率相关:无多重用药HR 0.88,多重用药HR 0.86,超多重用药HR 0.95(该组未达显著)。
  • 健康行为综合评分较高与较低全因死亡率相关:无多重用药HR 0.52,多重用药HR 0.55,超多重用药HR 0.69。

临床怎么用

  • 对多重用药和超多重用药的老年患者,仍应鼓励坚持地中海饮食、体力活动、戒烟等健康生活方式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Healthy lifestyle is associated with reduced all-cause mortality, but it is not known whether this association persists for individuals with high medication burden. We examined the association between healthy lifestyle behaviors and all-cause mortality across different degrees of polypharmacy. METHODS: This was a secondary analysis of 20,417 adults aged ≥45 years from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. The primary exposure was healthy lifestyle (adherence to Mediterranean diet, physical activity, smoking abstinence, sedentary behavior avoidance, and composite healthy behavior score [HBS]). The primary outcome was all-cause mortality. Strata of medication burden were based on the number of medications taken (no polypharmacy: 0-4, polypharmacy: 5-9, hyperpolypharmacy: ≥10). We used Cox proportional hazards regression models to examine the association between healthy lifestyle behaviors and mortality within each medication burden stratum and examined for interactions with age. RESULTS: The healthiest category of each lifestyle behavior, except sedentary behavior avoidance among the hyperpolypharmacy group, was associated with lower all-cause mortality (hazard ratio [HR]) regardless of medication burden: Mediterranean diet (no polypharmacy: HR 0.77, polypharmacy: HR 0.78, hyperpolypharmacy: HR 0.85), physical activity (no polypharmacy: HR 0.87, polypharmacy: HR 0.82, hyperpolypharmacy: HR 0.79), smoking abstinence (no polypharmacy: HR 0.40, polypharmacy: HR 0.45, hyperpolypharmacy: HR 0.52), and sedentary behavior avoidance (no polypharmacy: HR 0.88, polypharmacy: HR 0.86, hyperpolypharmacy: HR 0.95). Higher HBS was inversely associated with all-cause mortality within each medication burden stratum (no polypharmacy: HR 0.52, polypharmacy: HR 0.55, hyperpolypharmacy: HR 0.69). Although there was an interaction with age among those with no polypharmacy and those with polypharmacy, point estimates for HBS followed a graded pattern whereby higher HBS was incrementally associated with improved mortality across all age strata. CONCLUSION: Greater adherence to a healthy lifestyle was associated with lower all-cause mortality irrespective of medication burden and age.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Kelly NA, Soroka O, Onyebeke C, et al. Association of healthy lifestyle and all-cause mortality according to medication burden. J Am Geriatr Soc. 2021. PMID: 34695226. doi:10.1111/jgs.17521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。